Parents of Kids With Spinal Muscular Atrophy Are Worried About Signing Them up for Clinical Trials
Source: Pixabay

Parents of Kids With Spinal Muscular Atrophy Are Worried About Signing Them up for Clinical Trials

According to a story from SMA News Today, a recent study has demonstrated that the parents of children with spinal muscular atrophy are often skeptical about enrolling their kids in…

Continue Reading Parents of Kids With Spinal Muscular Atrophy Are Worried About Signing Them up for Clinical Trials
Investigational Gene Therapy for Spinal Muscular Atrophy Gets SAKIGAKE Designation
source: pixabay.com

Investigational Gene Therapy for Spinal Muscular Atrophy Gets SAKIGAKE Designation

According to a story from GlobeNewswire, The pharmaceutical company AveXis, Inc., a company that specializes in the development of gene therapies, recently announced that its candidate AVXS-101 was awarded SAKIGAKE…

Continue Reading Investigational Gene Therapy for Spinal Muscular Atrophy Gets SAKIGAKE Designation
The FDA is Beginning to Accept New Endpoints and “Real World” Data in Clinical Trials
vitalworks / Pixabay

The FDA is Beginning to Accept New Endpoints and “Real World” Data in Clinical Trials

According to a story from Charcot-Marie-Tooth Disease News, the U.S. Food and Drug Administration (FDA), under the leadership of commissioner Scott Gottlieb, has begun to change clinical trials by accepting…

Continue Reading The FDA is Beginning to Accept New Endpoints and “Real World” Data in Clinical Trials
Clinic Beats Slow Hospitals to be the First to Deliver Spinal Muscular Atrophy Drug in Michigan
source: pixabay.com

Clinic Beats Slow Hospitals to be the First to Deliver Spinal Muscular Atrophy Drug in Michigan

The day after Christmas in 2016 brought a post-Holiday surprise to many in the U.S. with spinal muscular atrophy. December 26, 2016 marked the day that Spinraza was approved by…

Continue Reading Clinic Beats Slow Hospitals to be the First to Deliver Spinal Muscular Atrophy Drug in Michigan
Spinraza, a New Drug For SMA Patients Might Be Available Sooner Than Later in the UK
Source: Pixabay

Spinraza, a New Drug For SMA Patients Might Be Available Sooner Than Later in the UK

There is new hope for patients and their families suffering from spinal muscular atrophy (SMA) reported AOL UK News. SMA is a physically debilitating and aggressive disease, and now a new…

Continue Reading Spinraza, a New Drug For SMA Patients Might Be Available Sooner Than Later in the UK
How to Help This Inspiring Non-Profit Supporting Families Facing Devastating Diagnoses
https://pixabay.com/en/book-heart-love-grains-sand-sea-2115176/

How to Help This Inspiring Non-Profit Supporting Families Facing Devastating Diagnoses

Earlier this year, Patient Worthy featured Ashley and her non-profit Love Not Lost – an organization that provides portrait sessions and photo albums for families dealing with a terminal illness…

Continue Reading How to Help This Inspiring Non-Profit Supporting Families Facing Devastating Diagnoses
AveXis, Gene Therapy Development Company, Expands Program
Source: Pixabay

AveXis, Gene Therapy Development Company, Expands Program

The gene therapy development company, AveXis, Incorporation, just announced that they will be expanding their clinical trial development program for the potential gene therapy treatment: AVXS-101, reported Globe News Wire.…

Continue Reading AveXis, Gene Therapy Development Company, Expands Program